Lv71
4120 积分 2021-12-06 加入
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
14天前
已完结
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
14天前
已关闭
GPRC5D-Targeted CAR T Cells for Myeloma
14天前
已关闭
GPRC5D-Targeted CAR T Cells for Myeloma
14天前
已完结
C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study
17天前
已完结
Perioperative Nivolumab in Resectable Lung Cancer
29天前
已完结
Transformation of indolent B-cell lymphomas
30天前
已关闭
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
1个月前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
1个月前
已关闭
Interview with Carlos Caldas
皖公网安备34019202002308
